Aspirin resistance and adverse clinical events in patients with coronary artery disease
about
Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME EraEsomeprazole and aspirin fixed combination for the prevention of cardiovascular eventsState-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry.Clinical determinants of aspirin resistance in diabetesRisk assessment and aspirin use in Asian and Western populations.Effect of glucose or fat challenge on aspirin resistance in diabetes.Platelet function tests: a comparative review.Sex differences in antiplatelet response in ischemic stroke.Aspirin resistance in the acute stages of acute ischemic stroke is associated with the development of new ischemic lesions.Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options.High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome.Aspirin resistance: disparities and clinical implications.A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregabilityAspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery DiseaseA clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes.Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smokingDosing strategies for antiplatelet therapy in percutaneous coronary intervention.Resistance to aspirin and clopidogrel therapy.Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention.Functional testing methods for the antiplatelet effects of aspirin.Antiplatelet therapy: aspirin resistance and all that jazz!Aspirin resistance: a clinical review focused on the most common cause, noncompliance.Global Trends in Aspirin Resistance-Related Research from 1990 to 2015: A Bibliometric Analysis.Aspirin responsiveness changes in obese patients following bariatric surgery.Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial.Aspirin resistance.Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry.Vascular and platelet responses to aspirin in patients with coronary artery disease.Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic Acid: a quantitative study in patients with cardiovascular risk.Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests.Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery.Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort.Obesity and Altered Aspirin Pharmacology.Aspirin's effect on platelet inhibition in migraineurs.Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81 mg.Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary Intervention.The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease
P2860
Q26745091-C627C8F9-96FF-4F46-8729-45EC3B959E3BQ26995752-C0D4F621-DAF0-4C13-B000-DA4C5B96BEE5Q30373414-3C9A3A20-BF8D-4EAC-9BF7-6528B1EC4B30Q33881728-16C9CD8E-773A-4EC2-8382-342A0E1A0F31Q34234687-7F199A52-97BB-45EF-9BA5-F4874337D871Q34245212-DB83D6A6-B386-4D4F-80E4-6591FB5B533BQ34557275-D87483FE-CCF2-48E3-938B-60C011F982B7Q35121464-6842ECAF-9202-49CF-8B48-976692178E2EQ35198604-2C6FE063-4295-464D-9D3D-A9E4F18C5F04Q35301978-F488A9C6-1F1B-4540-9D5B-4C7D0C5B993BQ35373683-E2BA8DBD-06B1-49FE-8F09-937CA1B7BDA0Q35797491-1DD0E369-E603-46B8-BC0F-A4D4C0868CE5Q37180923-D891CEA2-9D52-4016-A2F7-C29B0AC11BD6Q37227512-0B14581C-158B-4D97-8F45-E87B4B582CD8Q37336145-244301D9-CF76-413E-9EDA-5A178A19804CQ37527747-6529B241-E2E9-42EC-A341-CCE44F4E1E5DQ37550156-489710D9-4C2F-4008-966C-1C216846BC6BQ37678829-5D68BF0E-1268-45A4-B5A9-AB361F367F9BQ37752222-FB9F1CFF-FC1D-459E-B3F1-2A32406C38D7Q37807524-85A35BFB-2D66-4C68-A715-F8F77264DEE0Q37841560-EE840D6B-A332-4138-8EFA-E89B36D8F0FBQ37841562-7F517246-ECB4-437E-BC65-F4499F0713ADQ38023196-7447231A-E20D-4410-82AC-590C3F200EDCQ38132148-6BEED62C-A479-4C20-AE6E-27059A5C7CD2Q38664158-BBCC672F-B12C-4892-B330-5E9734FF7566Q38818898-34986EC8-736A-455C-8057-F0D8FEC38DA1Q42167771-69035025-525B-437E-A5DF-A722CF4A69BEQ42641720-95C15C93-C504-4DEA-93FD-B20F1A68AAC1Q43239552-961BFA2F-9145-48B1-9C4D-EFBE1B9FCDEDQ43255963-D458F75F-353F-4767-BBE2-ACA19745B9E9Q43970520-1758DD87-A3FC-4689-9C7B-B25827C52BD5Q44974747-53A8451D-1297-4A7A-AF26-076D6FDA4EB5Q45875469-B7584167-EFE3-46B5-9A2F-F2F20A1992B0Q46087815-658C2846-91EC-4CE8-B280-48CC3EA4A749Q47653562-23AB2892-7427-47BA-82F0-54A6FC608AE7Q48302820-5DA7A44C-AEF7-4836-9530-F70334848A2AQ51347759-630FC7E6-5084-401D-A66A-44FD1C6D7D6DQ53828870-AF526559-8D5F-40C2-A560-C66B1DC18FC1Q54217048-E6A1D20D-6473-45AA-BDE4-B0C22E384AE4Q58260743-D429A813-5DD1-460A-8D3E-28C22A8F3C67
P2860
Aspirin resistance and adverse clinical events in patients with coronary artery disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@ast
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@en
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@nl
type
label
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@ast
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@en
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@nl
prefLabel
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@ast
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@en
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@nl
P2093
P3181
P1476
Aspirin resistance and adverse clinical events in patients with coronary artery disease
@en
P2093
Chu-Pak Lau
Hung-Fat Tse
Jeanette Yat-Yin Kwok
Pui-Yin Lee
Wai-Hong Chen
William Ng
P3181
P356
10.1016/J.AMJMED.2006.10.021
P407
P577
2007-07-01T00:00:00Z